Table 1.
Baseline measures. Data are weighted for the sampling scheme.
| None of the psychiatric disorders | Anxiety or depressive disorder | Somatoform disorders, undifferentiated * | Somatoform disorder, others** | Total | |
| Patient characteristics (questionnaire) | (n = 274) | (n = 51) | (n = 94) | (n = 12) | (n = 400) |
| Gender (men) | 28% | 28% | 20% | 17% | 28% |
| Age: | |||||
| - 65 and over | 23% | 4% | 4% | 0% | 17% |
| - mean (se) | 52 (0.8) | 43 (1.3) | 45 (1.0) | 44 (2.8) | 49 (0.6) |
| Physical symptoms (PSC total score) | 4 (0.3) | 11 (1.1) | 10 (0.7) | 15 (3.0) | 6 (0.3) |
| Distress symptoms (HADS total score) | 8 (0.3) | 21 (1.1) | 15 (0.8) | 20 (2.3) | 11 (0.4) |
| Health status | |||||
| Somatic morbidity: | |||||
| - CIRS somatic morbidity score | 6.8 (0.2) | 7.5 (0.5) | 7.0 (0.4) | 6.8 (0.9) | 6.9 (0.2) |
| - Number of unique somatic prescriptions (FP or other) | 5.0 (0.3) | 6.3 (0.7) | 6.3 (0.5) | 5.7 (0.9) | 5.4 (0.2) |
| Psychiatric morbidity: | |||||
| - CIRS psychiatric severity score | 0.4 (0.0) | 1.5 (0.1) | 1.0 (0.1) | 1.7 (0.2) | 0.6 (0.0) |
| Use of anxiolytics (self report at time of interview) | 3% | 14% | 15% | 8% | 6% |
| Use of antidepressants (self report at time of interview) | 5% | 37% | 25% | 42% | 12% |
* Undifferentiated somatoform disorders included chronic pain disorders.
** Other somatoform disorders: hypochondriasis, somatization disorder and conversion disorder.